Baxter International (BAX) Non-Current Assets (2009 - 2026)
Baxter International's (BAX) quarterly Non-Current Assets came in at $12.8 billion in Q2 2026, down 10.46% year-over-year from $14.3 billion in Q2 2025, and down 1.52% quarter-over-quarter from $13.0 billion in Q1 2026.
Analysis
Baxter International (BAX) Non-Current Assets (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Non-Current Assets for 18 consecutive years, with $12.8 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 10.46% year-over-year to $12.8 billion in Q2 2026; TTM through Jun 2026 was $53.1 billion, a 16.09% decrease from a year earlier, with the FY2025 full-year figure at $13.2 billion, down 22.13% from the prior year.
- Non-Current Assets was $12.8 billion for Q2 2026 at Baxter International, down from $13.0 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $24.5 billion in Q1 2022 and troughed at $12.8 billion in Q2 2026.
- A 5-year average of $17.7 billion and a median of $18.1 billion in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets jumped 111.4% in 2022 and decreased 22.4% in 2025, its largest moves.
- Over 5 years, Non-Current Assets stood at $20.3 billion in 2022, then fell by 7.89% to $18.7 billion in 2023, then dropped by 9.35% to $16.9 billion in 2024, then declined by 22.13% to $13.2 billion in 2025, then slipped by 2.89% to $12.8 billion in 2026.
- The last three Non-Current Assets figures came in at $12.8 billion (Q2 2026), $13.0 billion (Q1 2026), and $13.2 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 42.59 Bn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 27.61 Bn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 2.27 Bn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 12.80 Bn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | - |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 88.31 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | 20.17 Mn |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | 75.77 Mn |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | 183,321.00 |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | 1.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.80 Bn |
| Mar 31, 2026 | 13.00 Bn |
| Dec 31, 2025 | 13.18 Bn |
| Sep 30, 2025 | 14.13 Bn |
| Jun 30, 2025 | 14.30 Bn |
| Mar 31, 2025 | 14.27 Bn |
| Dec 31, 2024 | 16.93 Bn |
| Sep 30, 2024 | 17.81 Bn |
| Jun 30, 2024 | 17.72 Bn |
| Mar 31, 2024 | 18.39 Bn |
| Dec 31, 2023 | 18.68 Bn |
| Sep 30, 2023 | 18.62 Bn |
| Jun 30, 2023 | 19.68 Bn |
| Mar 31, 2023 | 20.19 Bn |
| Dec 31, 2022 | 20.28 Bn |
| Sep 30, 2022 | 20.16 Bn |
| Jun 30, 2022 | 23.95 Bn |
| Mar 31, 2022 | 24.54 Bn |
| Dec 31, 2021 | 24.65 Bn |
| Sep 30, 2021 | 11.64 Bn |